By looking through the lenses of clinical research experts, it is possible to catch a glimpse into the future of humanity. Through the exploration and development of future medicines, medical treatments and regimens, researchers are able to assess new and unique remedies to treat a range of diverse and complicated illnesses.

Before long, these findings could potentially impact how the next generation of society exists. Living longer, feeling younger and looking younger are all distinctive ideals of our American culture and society. Though we know aging occurs inevitably, as we witness the internal and external changes of our bodies over time, many people find themselves concerned with how to slow these changes.

Whether the changes are chronic medical conditions or just minor displeasures, clinical research takes part in discovering ways to delay, prevent and possibly altogether avoid several effects that have a propensity to come with age.

Some critics say there is “no fighting fate.” However, clinical research keeps building a remarkable portfolio with the help of physicians displaying increasingly effective methods and treatments to delay the characteristics of age such as the early onset of various chronic or fatal diseases.

Because an extensive amount of physiological changes are related to aging, clinical research is able to link itself to several significant medical findings and treatments that are most commonly associated with aging. Such conditions examined in private practice clinical research range from diabetes and heart diseases to pain prevention, depression and menopause.

The most contemporary research suggests that various health issues people encounter as they age stem from the individual’s gene(s). For example, according to the American Association of Diabetes (ADA), “25.8 million children and adults in the United States – 8.3 percent of the population – have diabetes.”

Diabetes is a disease to which a person can be predisposed through genetics. However, research has proven that although diabetes may be part of one’s genetic makeup, it can be prevented by maintaining a healthy and fit lifestyle.

It has also been found that the susceptibility to diabetes varies by race and ethnicity. For example, ADA reports a “2007-2009 national survey data for people diagnosed with diabetes.” The following are the statistics for “race and ethnic differences in prevalence of diagnosed diabetes: 7.1 percent of non-Hispanic Whites, 8.4 percent of Asian Americans, 12.6 percent of non-Hispanic Blacks and 11.8 percent of Hispanics.”

As a result of findings and statistics by reputable organizations like ADA, clinical research is adapting and modifying how to investigate and carry out exclusive treatments for specific groups, ethnicities and races that are most susceptible to diseases like diabetes.

Medicine and medical treatments undergoing clinical research today have the capabilities of being distinctively modified for a group and uniquely personalized for the people most at risk. Since a treatment is specifically designed for a person with diabetes, each treatment is evaluated by its effectiveness on a specific group of people. Therefore, each person involved in the study must fit the model of an individual who would ideally use the drug for treatment.

In order to cater to the cultural differences in the ethnically or race-specific groups, the accumulation of anthropologic data of the individuals being treated is also required for the clinical study. It is important that the criteria are made specific so the drug is able to target certain subgroups of people.

While all of this explicit data is taken into careful consideration, the research and findings of the study enhance not only the drug being evaluated, but other medications and treatments in development, as well.

Because clinical research can be utilized in a private practice setting, more and more private clinics are catering to patients who are looking for more progressive and innovative physicians to be involved with as potential medical advisers for alternative treatments. This is so because the credentials of research means there are potential ways for the research physician to help the patient overcome a medical condition that may not be treatable otherwise.

Based on the specialized nature of private practice research, patients undergoing clinical research studies have the opportunity to access modern, specific treatments that are not yet available on the market.

The movement and progression of clinical research only leaves room for improvement and further opportunities for scientific advancements in treating chronic illnesses. None of these highlights on improving and personalizing upcoming medicines would be possible without the presence of clinical research. It is the essential tool for uncovering what the future of medicine and medical treatments hold for society.

Clinical research requires many spheres of professional collaboration for it to work; therefore, it continues to thrive in the workforce as a region of continual growth and development. It continues to lead our global nations to more medical advancements, and as a butterfly effect, to a healthier global community and future.

Synergyst Research contracts with physicians to assist with administrative duties and increase clinical research studies. In 2010, Synergyst Research negotiated more than 150 research studies in all specialties. Please visit Synergyst Research online at www.synergystresearch.net.

Discovery Clinical Trials partners with physicians to create research centers within private practices. In 2010, Discovery Clinical Trials implemented an additional 11 new research partnerships with physicians for a total of 19 partnership centers throughout the United States. Please visit Discovery Clinical Trials online at www.discoverytrials.com.

For more information, email sheri@synergyst.net or call 210-447-2073.